Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PC4 and SFRS1-interacting protein (PSIP1), widely known as Lens epithelium-derived growth factor (LEDGF/p75), is a chromatin-associated protein that functions as a transcriptional coactivator and a critical host factor for HIV-1 infection [UniProt O75475]. The PSIP1 mRNA encodes a protein that tethers the HIV-1 pre-integration complex to the host cell's chromatin, specifically directing viral integration into transcriptionally active regions of the genome [PubMed: 21115976]. Beyond its role in viral pathogenesis, PSIP1 is involved in cellular stress responses, DNA damage repair, and the regulation of cell survival pathways [PubMed: 23835560]. In oncology, PSIP1 is frequently overexpressed and has been implicated in the progression of various malignancies, including leukemia and prostate cancer, where it promotes resistance to apoptosis [PubMed: 26334377]. Therapeutic targeting of PSIP1 primarily focuses on disrupting its interaction with HIV-1 integrase using small molecules called LEDGINs or utilizing RNA interference (RNAi) to knockdown PSIP1 mRNA levels [PubMed: 22423967]. However, because PSIP1 is essential for maintaining normal cellular homeostasis and genomic stability, therapeutic strategies must carefully manage the risk of off-target effects on host transcription and DNA repair [PubMed: 25108353].
RNA interference-mediated degradation of mRNA; Allosteric inhibition of HIV-1 integrase binding to the LEDGF/p75 protein product
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PC4 and SFRS1-interacting protein (PSIP1) (PSIP1).